| Basics |
Mannatech, Incorporated Common Stock
Mannatech Inc develops and sells nutritional supplements, topical and skin care products, and weight-management products. Its products portfolio includes Ambrotose complex, Ambrotose AO, NutriVerus, and OsoLean, among others.
|
| IPO Date: |
February 16, 1999 |
| Sector: |
Consumer Staples |
| Industry: |
Personal Products |
| Market Cap: |
$18.32M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.34 | 2.72%
|
| Avg Daily Range (30 D): |
$0.30 | 2.99%
|
| Avg Daily Range (90 D): |
$0.45 | 3.90%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.06M |
| Avg Daily Volume (30 D): |
.01M |
| Avg Daily Volume (90 D): |
.01M |
| Trade Size |
| Avg Trade Size (Sh.): |
207 |
| Avg Trade Size (Sh.) (30 D): |
66 |
| Avg Trade Size (Sh.) (90 D): |
52 |
| Institutional Trades |
| Total Inst.Trades: |
107 |
| Avg Inst. Trade: |
$1.02M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.3M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
38.92K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.86
|
$1.01
|
|
|
Diluted EPS
|
$-.86
|
$1.01
|
|
|
Revenue
|
$ 110.41M
|
$ 29.16M
|
$
|
|
Gross Profit
|
$ 84.27M
|
$ 22.27M
|
$
|
|
Net Income / Loss
|
$ -1.66M
|
$ 1.92M
|
$ -4.31M
|
|
Operating Income / Loss
|
$ .6M
|
$ 2.01M
|
$
|
|
Cost of Revenue
|
$ 26.14M
|
$ 6.89M
|
$
|
|
Net Cash Flow
|
$ -5.99M
|
$
|
$
|
|
PE Ratio
|
|
|
|
| Splits |
|
Jan 17, 2012:
1:10
|
|
|
|
